Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells

被引:24
作者
Huertas, D [1 ]
Howe, S [1 ]
McGuigan, A [1 ]
Huxley, C [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England
关键词
D O I
10.1093/hmg/9.4.617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasmids carrying the origin of plasmid replication (oriP) and expressing the EBNA-1 protein from the Epstein-Barr virus replicate and segregate in human cells and are thus potentially useful vectors for gene therapy. As very large circular molecules, up to 660 kb in size, can be maintained episomally using this system, it is possible to include intact human genes with all their long-range controlling elements which might give high levels of tissue-specific and controlled gene expression, We have shown previously that a 320 kb yeast artificial chromosome (YAC) carrying the intact human CFTR gene can complement the Cambridge null cystic fibrosis mice as a transgene, We have now modified this YAC to a circular molecule carrying both oriP and the EBNA-1 gene. We show that this oriP-EBNA1-YAC can be stably maintained as unrearranged episomes in mouse LA-9 cells, which do not express endogenous cftr, and in mouse CMT-93 cells, which do express endogenous cftr, The human CFTR gene is expressed in some of the cell lines, but the level of expression is very variable between cell lines and is not related to the copy number of the elements.
引用
收藏
页码:617 / 629
页数:13
相关论文
共 47 条
[1]   Towards gene therapy for cystic fibrosis: a clinical progress report [J].
Alton, EWFW ;
Geddes, DM ;
Gill, DR ;
Higgins, CF ;
Hyde, SC ;
Innes, JA ;
Porteous, DJ .
GENE THERAPY, 1998, 5 (03) :291-292
[2]   NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE [J].
ALTON, EWFW ;
MIDDLETON, PG ;
CAPLEN, NJ ;
SMITH, SN ;
STEEL, DM ;
MUNKONGE, FM ;
JEFFERY, PK ;
GEDDES, DM ;
HART, SL ;
WILLIAMSON, R ;
FASOLD, KI ;
MILLER, AD ;
DICKINSON, P ;
STEVENSON, BJ ;
MCLACHLAN, G ;
DORIN, JR ;
PORTEOUS, DJ .
NATURE GENETICS, 1993, 5 (02) :135-142
[3]   A YEAST ARTIFICIAL CHROMOSOME CONTIG ENCOMPASSING THE CYSTIC-FIBROSIS LOCUS [J].
ANAND, R ;
OGILVIE, DJ ;
BUTLER, R ;
RILEY, JH ;
FINNIEAR, RS ;
POWELL, SJ ;
SMITH, JC ;
MARKHAM, AF .
GENOMICS, 1991, 9 (01) :124-130
[4]   THERAPEUTIC GENE DELIVERY IN HUMAN BETA-LYMPHOBLASTOID CELLS BY ENGINEERED NON-TRANSFORMING INFECTIOUS EPSTEIN-BARR-VIRUS [J].
BANERJEE, S ;
LIVANOS, E ;
VOS, JMH .
NATURE MEDICINE, 1995, 1 (12) :1303-1308
[5]   CLONING OVERLAPPING DNA FRAGMENTS FROM THE B95-8 STRAIN OF EPSTEIN-BARR VIRUS REVEALS A SITE OF HOMOLOGY TO THE INTERNAL REPETITION [J].
BUELL, GN ;
REISMAN, D ;
KINTNER, C ;
CROUSE, G ;
SUGDEN, B .
JOURNAL OF VIROLOGY, 1981, 40 (03) :977-982
[6]   TRANSFORMATION OF YEAST SPHEROPLASTS WITHOUT CELL-FUSION [J].
BURGERS, PMJ ;
PERCIVAL, KJ .
ANALYTICAL BIOCHEMISTRY, 1987, 163 (02) :391-397
[7]   CLONING OF LARGE SEGMENTS OF EXOGENOUS DNA INTO YEAST BY MEANS OF ARTIFICIAL CHROMOSOME VECTORS [J].
BURKE, DT ;
CARLE, GF ;
OLSON, MV .
SCIENCE, 1987, 236 (4803) :806-812
[8]   The potential of extrachromosomal replicating vectors for gene therapy [J].
Calos, MP .
TRENDS IN GENETICS, 1996, 12 (11) :463-466
[9]   TARGETED ALTERATIONS IN YEAST ARTIFICIAL CHROMOSOMES FOR INTERSPECIES GENE-TRANSFER [J].
DAVIES, NP ;
ROSEWELL, IR ;
BRUGGEMANN, M .
NUCLEIC ACIDS RESEARCH, 1992, 20 (11) :2693-2698
[10]   THE EPSTEIN-BARR VIRUS ORIGIN OF PLASMID REPLICATION, ORIP, CONTAINS BOTH THE INITIATION AND TERMINATION SITES OF DNA-REPLICATION [J].
GAHN, TA ;
SCHILDKRAUT, CL .
CELL, 1989, 58 (03) :527-535